Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Prevention of mother-to-child transmission news


From To
Dolutegravir: need to consider all pros and cons before switching in pregnancy

A young pregnant woman who switched from dolutegravir (DTG)-based ART, in response to the neural tube defect safety signal, experienced viral rebound on her new regimen. She needed to be switched back to DTG to achieve re-suppression and prevent vertical transmission.

11 July 2018
HIV i-Base
New contraindication against using darunavir/cobicistat during pregnancy

On 22 June 2018, Janssen issued a Dear Doctor letter (linked below) against using darunavir/cobicistat during pregnancy. This new contraindication is based on significantly reduced plasma levels of darunavir and cobicistat during the second and third trimesters of pregnancy. Darunavir can still be used during pregnancy, but only when boosted by ritonavir.

25 June 2018
HIV i-Base
Yes, HIV-Positive Men Can Become Fathers. Here's Two Providers Who Help Them

In HIV, we pay a lot of attention to parenthood -- but mostly from the perspective of ending mother-to-child transmission. Even then, the public health message is often mostly about the baby, not the health and well-being of the mother. But almost nowhere do we have deep discussions about reproductive options for HIV-positive men, particularly cisgender straight men.

18 June 2018
Nigeria has more HIV-infected babies than anywhere in the world. It’s a distinction no country wants

At a time when rates of mother-to-child transmission of HIV have plummeted, even in far poorer countries, Nigeria accounted for 37,000 of the world’s 160,000 new cases of babies born with HIV in 2016.

13 June 2018
The End of AIDS: Far from Over

The tools exist. HIV/AIDS can be treated and contained. But in many communities, social, political and economic obstacles get in the way. There, the epidemic is far from over. PBS Newshour reports from Russian, Nigeria and Florida.

12 June 2018
PBS NewsHour
FDA says Prezcobix should not be given to pregnant women

Darunavir/cobicistat — marketed as Prezcobix (Janssen) in the United States — should not be given to pregnant women with HIV because of substantially lower exposures of the two medications during pregnancy, the FDA said. The agency updated the label for the once-daily, fixed-dose tablet to reflect the change, which it said was based on data from a small clinical trial involving pregnant women.

11 June 2018
Healio (requires free registration)
Irish mums diagnosed with HIV worry more about how diagnosis will affect family than themselves, study finds

Aside from worrying about passing HIV on, these mothers tend to prioritise the needs of the family at the expense of their own healthcare on a day-to-day basis

08 May 2018
Irish Mirror
Mother-to-child HIV transmission at all-time low in the UK but around two-thirds of reported cases involve women diagnosed after delivery

Factors such as uncertain immigration status, housing problems and intimate partner violence are common among women who pass on HIV to their infants in the

02 May 2018
Michael Carter
Anti-HIV drug combination does not increase preterm birth risk, study suggests

A drug combination aimed at preventing transmission of HIV from a pregnant woman to her fetus likely does not increase the risk for preterm birth and early infant death, according to a re-analysis of two studies funded by the National Institutes of Health. The research appears in the New England Journal of Medicine.

26 April 2018
National Institutes of Health
Giving birth has become less dangerous in South Africa

The main reason for South Africa’s decline in maternal death ratios, according to the SAMJ study, is the “large-scale reduction in deaths owing to HIV infection as a result of the success of the HIV antiviral treatment programme in pregnancy and beyond”.

04 April 2018

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.